Company Cyber Security Posture
NANA
NA Company Details
NA
NA
NA
NA
NA
NA
Scan still pending
NA
NA
NA Risk Score (AI oriented)Between 200 and 800
This score is AI-generated and less favored by cyber insurers, who prefer the TPRM score.
NA Global Score.png)
Company Scoring based on AI Models
| Model Name | Date | Description | Current Score Difference | Score |
|---|---|---|---|---|
| AVERAGE-Industry | 03-12-2025 | This score represents the average cybersecurity rating of companies already scanned within the same industry. It provides a benchmark to compare an individual company's security posture against its industry peers. | N/A | Between 200 and 800 |
Company Cyber Security News & History
| Entity | Type | Severity | Impact | Seen | Url ID | Details | View |
|---|
Company Subsidiaries
NA
Access Data Using Our API
Get company history
Rapid.png)
NA Cyber Security News
Weil Advises Sanofi in its $9.5 Billion Acquisition of Blueprint Medicines
Blueprint Medicines is a U.S.-based, publicly traded biopharmaceutical company specializing in systemicmastocytosis (SM), ...
Sanofi to Buy Blueprint Medicines for Up to $9.5 Billion in Boost to Pipeline
The deal with Blueprint, a Cambridge, Mass.-based immunology-disease specialist, is set to give Sanofi ownership over both an approved drug and ...
Sanofi to expand immunology offerings with Blueprint Medicines
Sanofi CEO Paul Hudson stated: “The proposed acquisition of Blueprint Medicines represents a strategic step forward in our rare and immunology ...
Why is health care cybersecurity so bad?
In this video, STAT health tech reporter Brittany Trang explains why health care cybersecurity is so bad — and what the government and health ...
Mature But Vulnerable: Pharmaceutical Sector's Cyber Reality
The supply chain in the pharmaceutical sector is a "complex, independent thing," said Mullen, vice president and leader of Booz Allen Hamilton's ...
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio.
Commission launches new cybersecurity blueprint to enhance EU cyber crisis co-ordination
The Commission has presented a proposal to ensure an effective and efficient response to large-scale cyber incidents.
Trump proposes $163 billion cut to US budget that slashes domestic spending
Trump's first budget since reclaiming office seeks to make good on his promises to boost spending on border security while slashing the ...
NA Similar Companies
CSL
CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by ou
The National Institutes of Health
NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness an
Gilead Sciences
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy healt
Talecris Plasma Resources
Talecris Plasma Resources was established in 2006 to ensure a reliable and safe supply of plasma for the production of premium protein therapies that help save and enhance lives worldwide. Today, we are a nationwide network of 69 plasma collection centers guided by our unwavering commitment to safet
Charles River Laboratories
At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all
Biocon
Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global healthc
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
NA CyberSecurity History Information
How many cyber incidents has NA faced?
Total Incidents: According to Rankiteo, NA has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at NA?
Incident Types: The types of cybersecurity incidents that have occurred include .
Additional Questions
What Do We Measure?
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
